ELI LILLY & Co is 294.7x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($1.072 T vs $3.64 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ACAD | LLY |
|---|---|---|
| Market cap | $3.64 B | $1.072 T |
| US-listed rank | #1650 | #10 |
| Revenue (latest FY) | $1.07B | $65.18B |
| Net income (latest FY) | $391.00M | $20.64B |
| Net margin | 36.5% | 31.7% |
| P/E (trailing FY) | 9.3 | 51.9 |
| SEC filings | 1,357 | 989 |
ELI LILLY & Co is 294.7x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($1.072 T vs $3.64 B).
In their latest fiscal years, ACADIA PHARMACEUTICALS INC reported $1.07B in revenue while ELI LILLY & Co reported $65.18B.
Full pages: ACADIA PHARMACEUTICALS INC and ELI LILLY & Co, or browse the full rankings.